Evidence mapPaperPMID 33714226Full record

Trial reportJournal of diabetes investigation2021

Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control.

Georgios Ponirakis, Muhammad A Abdul-Ghani, Amin Jayyousi, Mahmoud A Zirie, Murtaza Qazi, Hamad Almuhannadi, Ioannis N Petropoulos, Adnan Khan, Hoda Gad, Osama Migahid and 9 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of diabetes investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Advances in GLP-1 receptor agonists for pain treatment and their future potential.The journal of headache and pain · 2025 · on this map
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Current Perspectives in Pre- and Diabetic Peripheral Neuropathy Diagnosis and Management: An Expert Statement for the Gulf Region.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Georgios PonirakisWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.ORCID https://orcid.org/0000-0002-6936-1248
Muhammad A Abdul-GhaniNational Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Amin JayyousiNational Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Mahmoud A ZirieNational Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Murtaza QaziWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Hamad AlmuhannadiWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Ioannis N PetropoulosWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Adnan KhanWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.ORCID https://orcid.org/0000-0003-4647-6672
Hoda GadWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Osama MigahidNational Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Ayman MegahedNational Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Salma Al-MohannadiWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.ORCID https://orcid.org/0000-0003-1553-848X
Fatema AlMarriWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Fatima Al-KhayatWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Ziyad MahfoudWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Hanadi Al HamadRumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
Marwan RamadanRumailah Hospital, Hamad Medical Corporation, Doha, Qatar.
Ralph DeFronzoDivision of Diabetes, University of Texas Health Science Center, San Antonio, Texas, USA.
Rayaz A MalikWeill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.ORCID https://orcid.org/0000-0002-7188-8903
Weill Cornell Medical College in Qatar · QAHamad General Hospital · QAThe University of Texas Health Science Center at San Antonio · USHamad Medical Corporation · QAManchester Metropolitan University · GB

Funding

Qatar National Research Fund BMRP-5726113101Qatar National Research Fund NPRP 5-273-3-079
6 · The paper itself

Abstract

AIMS/

introductionPainful diabetic peripheral neuropathy (pDPN) is associated with small nerve fiber degeneration and regeneration. This study investigated whether the presence of pDPN might influence nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control. MATERIALS AND

methodsThis exploratory substudy of an open-label randomized controlled trial undertook the Douleur Neuropathique en 4 questionnaire and assessment of electrochemical skin conductance, vibration perception threshold and corneal nerve morphology using corneal confocal microscopy in participants with and without pDPN treated with exenatide and pioglitazone or basal-bolus insulin at baseline and 1-year follow up, and 18 controls at baseline only.

resultsParticipants with type 2 diabetes, with (n = 13) and without (n = 28) pDPN had comparable corneal nerve fiber measures, electrochemical skin conductance and vibration perception threshold at baseline, and pDPN was not associated with the severity of DPN. There was a significant glycated hemoglobin reduction (P < 0.0001) and weight gain (P < 0.005), irrespective of therapy. Participants with pDPN showed a significant increase in corneal nerve fiber density (P < 0.05), length (P < 0.0001) and branch density (P < 0.005), and a decrease in the Douleur Neuropathique en 4 score (P < 0.01), but no change in electrochemical skin conductance or vibration perception threshold. Participants without pDPN showed a significant increase in corneal nerve branch density (P < 0.01) and no change in any other neuropathy measures. A change in the severity of painful symptoms was not associated with corneal nerve regeneration and medication for pain.

conclusionsThis study showed that intensive glycemic control is associated with greater corneal nerve regeneration and an improvement in the severity of pain in patients with painful diabetic neuropathy.

Indexed as

Nerve RegenerationAdolescentAdultAgedBiomarkersBlood GlucoseCase-Control StudiesCorneaDiabetes Mellitus, Type 2Diabetic NeuropathiesFemaleFollow-Up StudiesGlycated HemoglobinGlycemic ControlHumansHypoglycemic AgentsBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsCorneal confocal microscopyExenatidePainful diabetic neuropathy

Identifiers

PMID33714226
PMCPMC8409832
OpenAlexW3138326889

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.